199 related articles for article (PubMed ID: 37722570)
41. Proteomic identification of predictive biomarkers for malignant transformation in complete hydatidiform moles.
Vanichtantikul A; Hodge KG; Somparn P; Saethang T; Triratanachat S; Pisitkun T; Lertkhachonsuk R
Placenta; 2019 Feb; 77():58-64. PubMed ID: 30827356
[TBL] [Abstract][Full Text] [Related]
42. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high-risk and low-risk gestational trophoblastic disease.
Khazaeli MB; Buchina ES; Pattillo RA; Soong SJ; Hatch KD
Am J Obstet Gynecol; 1989 Feb; 160(2):444-9. PubMed ID: 2464935
[TBL] [Abstract][Full Text] [Related]
43. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
Dantas PR; Maestá I; Cortés-Charry R; Growdon WB; Braga A; Rudge MV; Berkowitz RS
J Reprod Med; 2012; 57(7-8):305-9. PubMed ID: 22838246
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of the risk of persistent trophoblastic disease after twin pregnancy with diploid hydatidiform mole and coexisting normal fetus.
Niemann I; Sunde L; Petersen LK
Am J Obstet Gynecol; 2007 Jul; 197(1):45.e1-5. PubMed ID: 17618752
[TBL] [Abstract][Full Text] [Related]
45. Complete hydatidiform mole in higher-order multiple pregnancies.
Sileo FG; Giuliani GA; Facchinetti F; Contu G; Chiossi G; Bertucci E
Minerva Obstet Gynecol; 2022 Jun; 74(3):308-313. PubMed ID: 35642715
[TBL] [Abstract][Full Text] [Related]
46. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
47. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
Coyle C; Short D; Jackson L; Sebire NJ; Kaur B; Harvey R; Savage PM; Seckl MJ
Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
[TBL] [Abstract][Full Text] [Related]
48. Clinical features of early-stage nonhydropic mole for diagnosis of persistent trophoblastic disease.
Miyoshi J; Ohba T; Fukunaga M; Katabuchi H
Obstet Gynecol; 2011 Oct; 118(4):847-53. PubMed ID: 21934448
[TBL] [Abstract][Full Text] [Related]
49. Metastatic complete hydatidiform mole with a surviving coexistent twin. A case report.
Kauffman DE; Sutkin G; Heine RP; Watt-Morse M; Price FV
J Reprod Med; 1999 Feb; 44(2):131-4. PubMed ID: 10853445
[TBL] [Abstract][Full Text] [Related]
50. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
Bagshawe KD; Lawler SD; Paradinas FJ; Dent J; Brown P; Boxer GM
Lancet; 1990 May; 335(8697):1074-6. PubMed ID: 1970378
[TBL] [Abstract][Full Text] [Related]
51. The current situation of health services for hydatidiform mole in Cambodia.
Yamamoto E; Kanal K; Soeung SC; Fujita N; Krang S; Long-Hay P; Nishino K; Niimi K; Hamajima N
J Obstet Gynaecol Res; 2021 Oct; 47(10):3652-3660. PubMed ID: 34342367
[TBL] [Abstract][Full Text] [Related]
52. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
53. Persistent gestational trophoblastic tumour with partial hydatidiform mole as the antecedent pregnancy.
Chen RJ; Huang SC; Chow SN; Hsieh CY; Hsu HC
Br J Obstet Gynaecol; 1994 Apr; 101(4):330-4. PubMed ID: 8199080
[TBL] [Abstract][Full Text] [Related]
54. The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.
Baasanjav B; Usui H; Kihara M; Kaku H; Nakada E; Tate S; Mitsuhashi A; Matsui H; Shozu M
Hum Reprod; 2010 May; 25(5):1183-91. PubMed ID: 20208060
[TBL] [Abstract][Full Text] [Related]
55. [Gestational trophoblastic neoplasia after spontaneous normalization of human chorionic gonadotropin in patient with partial hydatidiform mole].
Matos M; Ferraz L; Lopes Pde F; Lozoya C; Amim Junior J; Rezende-Filho J; Braga A
Rev Bras Ginecol Obstet; 2015 Jul; 37(7):339-43. PubMed ID: 26247255
[TBL] [Abstract][Full Text] [Related]
56. Sonographic findings and perinatal outcome of multiple pregnancies associating a complete hydatiform mole and a live fetus: a case series.
Kutuk MS; Ozgun MT; Dolanbay M; Batukan C; Uludag S; Basbug M
J Clin Ultrasound; 2014 Oct; 42(8):465-71. PubMed ID: 24867873
[TBL] [Abstract][Full Text] [Related]
57. Risk of recurrent molar pregnancies following complete and partial hydatidiform moles.
Eagles N; Sebire NJ; Short D; Savage PM; Seckl MJ; Fisher RA
Hum Reprod; 2015 Sep; 30(9):2055-63. PubMed ID: 26202916
[TBL] [Abstract][Full Text] [Related]
58. Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type.
Schmitt C; Doret M; Massardier J; Hajri T; Schott AM; Raudrant D; Golfier F
Gynecol Oncol; 2013 Jul; 130(1):86-9. PubMed ID: 23523617
[TBL] [Abstract][Full Text] [Related]
59. Twin pregnancy with a complete hydatidiform mole and surviving co-existent fetus.
Piura B; Rabinovich A; Hershkovitz R; Maor E; Mazor M
Arch Gynecol Obstet; 2008 Oct; 278(4):377-82. PubMed ID: 18273627
[TBL] [Abstract][Full Text] [Related]
60. ABO blood type compatibility is not a risk factor for gestational trophoblastic neoplasia development from androgenetic complete hydatidiform moles.
Sato A; Usui H; Shozu M
Am J Reprod Immunol; 2020 Jun; 83(6):e13237. PubMed ID: 32191360
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
